🔗 Visit the ClinicalTrials.gov page for NCT04369820
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. | N Engl J Med | 2020 | 10.90 |
| 2 | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. | Lancet | 2020 | 10.16 |
| 3 | Clinical Characteristics of Coronavirus Disease 2019 in China. | N Engl J Med | 2020 | 9.53 |
| 4 | Protective effects of C5a blockade in sepsis. | Nat Med | 1999 | 2.50 |
| 5 | Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. | JAMA | 2020 | 2.23 |
| 6 | Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. | J Clin Invest | 1986 | 1.71 |
| 7 | The role of C5a in acute lung injury induced by highly pathogenic viral infections. | Emerg Microbes Infect | 2015 | 0.77 |